Jump to navigation
As Americans began receiving Pfizer's COVID-19 vaccine this week, UArizona immunobiologist Deepta Bhattacharya talked about the science, development and safety of the vaccine.
Twenty percent of Arizona grocery store workers surveyed say they have experienced severe levels of mental distress during the pandemic. A major source of that stress: customer behavior.
The University of Arizona's ultracold storage facility could play an important role in the state's plan for vaccine distribution.
UArizona Health Sciences immunobiologists have created a five-module chimeric antigen receptor T cell that is showing early potential to fight Type 1 diabetes.
Inspired by her work at an orphanage in Romania, Dr. Katalin Gothard aims to understand how the brain interprets the social, emotional and physical aspects of touch.
The Arizona CoVHORT study will answer questions about risk factors for severe COVID-19 infection and how the virus impacts long-term health.
A study led by Dr. Julie Bauman will be expanded to further investigate the safety and effectiveness of a personalized cancer vaccine.
UArizona researchers have developed a method of using ketamine in the treatment of Parkinson’s disease. The discovery has been licensed to Pharmather Inc. for development and commercialization.
Dr. Sairam Parthasarathy is one of 11 principal investigators for the National Institutes of Health Community Engagement Alliance Against COVID-19 Disparities.
Researchers have developed a rapid, simplified method for producing radio-labeling compounds used for PET scans.
